Research Categories
- Anesthesia
- Arthroscopy
- Biologics/Biomaterials
- Cancer Devices
- Cardiovascular
- Cosmetic Devices
- Dental
- Diabetes
- Diagnostics
- Dialysis
- Drug Delivery
- Ear, Nose, Throat
- Endoscopy
- Gastrointestinal (GI)
- General Surgery
- Gynecology Devices
- Healthcare IT
- Hearing Devices
- Imaging
- Immunology
- Infusion Therapy
- Laparoscopy
- Minimally Invasive Surgery
- Neurology Devices
- Oncology
- Operating Room Equipment
- Ophthalmics Devices
- Orthopedics
- Patient Monitoring
- Peripheral Vascular
- Respiratory Devices
- Robotics & Navigation
- Sleep Apnea & Diagnostics
- Spine
- Stents
- Tissue Repair
- Urology
- Vascular Access
- Video Hi-Tech
- Women's Health
- Wound Care
Craniomaxillofacial (CMF)
The markets for craniomaxillofacial (CMF) devices and the biologics used in CMF and neurosurgical procedures including: plates and screws, bone graft substitutes, cranial flap fixation, dural repair and temporomandibular joint (TMJ) as well as products used in thoracic surgery for sternal closure as many manufacturers often group these products within their CMF portfolio.
Showing all 9 results
Orthopedic Biomaterials Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, Cellular Allografts, and 3 more
The full report suite on the U.S. market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrices (DBMs), xenografts and synthetic bone graft markets. The report also includes orthopedic growth factors; cellular allografts; orthopedic cell therapy, represented by bone marrow aspirate concentrate and platelet-rich plasma; hyaluronic acid (HA) viscosupplementation in single-, two-, three- and five-injection cycles; and, finally, orthopedic cartilage repair. Cartilage repair is represented by the osteochondral allograft, meniscal allograft, autologous chondrocyte implantation, particulated juvenile allograft and microfracture adjunct segments.
more...Orthobiologics Market Analysis, Size, Trends | China | 2020-2026 | MedSuite
In 2020, the Chinese orthobiologics market size was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026. Throughout this medical market research, we analyzed 28 orthobiologics companies across China […]
more...Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite
In 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR). Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our […]
more...Orthobiologics Market Analysis, Size, Trends | India | 2020-2026 | MedSuite
In 2020, the Indian orthobiologics market size was valued at $76.2 million, with over 520,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 12.4% to reach $172.3 million in 2026. Throughout this medical market research, we analyzed 23 orthobiologics companies across India […]
more...Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite
In 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026. Throughout this medical market research, we analyzed 16 orthobiologics companies across […]
more...Orthobiologics Market Analysis, Size, Trends | Australia | 2020-2026 | Medsuite
In 2020, the Australian orthobiologics market size was valued at $63.8 million, with over 29,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 4.9% to reach $89.4 million in 2026. Throughout this medical market research, we analyzed 48 orthobiologics companies across Australia […]
more...Craniomaxillofacial and Thoracic Surgery Devices Market Report Suite | United States | 2015-2021 | MedSuite
This report covers the markets for craniomaxillofacial (CMF) devices and the biologics used in CMF and
neurosurgical procedures including: plates and screws, bone graft substitutes, cranial flap fixation, dural
repair and temporomandibular joint (TMJ). The report also includes products used in thoracic surgery for
sternal closure as many manufacturers often group these products within their CMF portfolio.